
Older adults may have a second vaccine option for RSV following the U.S. Food and Drug Administration’s approval of a Pfizer vaccine on Wednesday. The other shot for adults 60 and up is made by GSK. It was approved May 3. Both should be available by fall, before the seasonal spread of respiratory syncytial virus… read on > read on >